X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | ACET | Kauffman Michael | Dir | S - Sale+OE | $1.43 | -5,900 | 5,900 | -50% | -$8,437 | |||||
2024-01-25 | ACET | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $2.40 | +3,125,000 | 2,930,527 | -1607% | +$7,500,000 | ||||||
2024-01-25 | ACET | Gordon Carl L | Dir, 10% | P - Purchase | $2.40 | +3,125,000 | 2,930,527 | -1607% | +$7,500,000 | ||||||
| M | 2023-09-28 | ACET | Schor Chen | Pres, CEO | S - Sale | $1.39 | -11,000 | 250,654 | -4% | -$15,291 | |||||
| M | 2023-09-28 | ACET | Schor Chen | Pres, CEO | P - Purchase | $1.38 | +11,000 | 250,654 | +5% | +$15,150 | |||||
2023-06-30 | ACET | Dubin Steve | Dir | P - Purchase | $2.40 | +5,000 | 10,900 | +85% | +$12,000 | ||||||
2023-06-27 | ACET | Gordon Carl L | Dir, 10% | P - Purchase | $2.09 | +875,000 | 962,339 | >999% | +$1,828,750 | ||||||
2023-06-27 | ACET | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $2.09 | +875,000 | 962,339 | >999% | +$1,828,750 | ||||||
2023-02-15 | ACET | Healey Don | CTO | S - Sale | $7.57 | -4,533 | 66,568 | -6% | -$34,327 | ||||||
2023-02-10 | ACET | Healey Don | CTO | S - Sale | $7.98 | -10,467 | 71,101 | -13% | -$83,476 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |